PCK2 and hepatocellular carcinoma: In our investigation, a number of bioinformatics datasets, including TCGA, CPTAC, and HPA, were utilized to prove the discrepancies in the expression of PCK2 in hepatocellular carcinoma tissues and normal adjacent tissues at different levels.